Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Pneumonia recovery reprograms the alveolar macrophage pool
Antoine Guillon, Emad I. Arafa, Kimberly A. Barker, Anna C. Belkina, Ian Martin, Anukul T. Shenoy, Alicia K. Wooten, Carolina Lyon De Ana, Anqi Dai, Adam Labadorf, Jaileene Hernandez Escalante, Hans Dooms, Hélène Blasco, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Joseph P. Mizgerd
Antoine Guillon, Emad I. Arafa, Kimberly A. Barker, Anna C. Belkina, Ian Martin, Anukul T. Shenoy, Alicia K. Wooten, Carolina Lyon De Ana, Anqi Dai, Adam Labadorf, Jaileene Hernandez Escalante, Hans Dooms, Hélène Blasco, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Joseph P. Mizgerd
View: Text | PDF
Research Article Pulmonology

Pneumonia recovery reprograms the alveolar macrophage pool

  • Text
  • PDF
Abstract

Community-acquired pneumonia is a widespread disease with significant morbidity and mortality. Alveolar macrophages are tissue-resident lung cells that play a crucial role in innate immunity against bacteria that cause pneumonia. We hypothesized that alveolar macrophages display adaptive characteristics after resolution of bacterial pneumonia. We studied mice 1 to 6 months after self-limiting lung infections with Streptococcus pneumoniae, the most common cause of bacterial pneumonia. Alveolar macrophages, but not other myeloid cells, recovered from the lung showed long-term modifications of their surface marker phenotype. The remodeling of alveolar macrophages was (a) long-lasting (still observed 6 months after infection), (b) regionally localized (observed only in the affected lobe after lobar pneumonia), and (c) associated with macrophage-dependent enhanced protection against another pneumococcal serotype. Metabolomic and transcriptomic profiling revealed that alveolar macrophages of mice that recovered from pneumonia had new baseline activities and altered responses to infection that better resembled those of adult humans. The enhanced lung protection after mild and self-limiting bacterial respiratory infections includes a profound remodeling of the alveolar macrophage pool that is long-lasting; compartmentalized; and manifest across surface receptors, metabolites, and both resting and stimulated transcriptomes.

Authors

Antoine Guillon, Emad I. Arafa, Kimberly A. Barker, Anna C. Belkina, Ian Martin, Anukul T. Shenoy, Alicia K. Wooten, Carolina Lyon De Ana, Anqi Dai, Adam Labadorf, Jaileene Hernandez Escalante, Hans Dooms, Hélène Blasco, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Joseph P. Mizgerd

×

Figure 9

Transcripts and proteins altered by prior pneumonia experience.

Options: View larger image (or click on image) Download as PowerPoint
Transcripts and proteins altered by prior pneumonia experience.
Transcri...
Transcripts were culled from the full data sets of alveolar macrophages from naive or experienced mice with or without acute (4-hour) infections by serotype 3 pneumococcus and presented in A–D. (A) The 25 transcripts that increased most significantly due to past history of infections. These had the lowest FDR q values for effect of pneumonia history and were increased rather than decreased in alveolar macrophages of experienced lungs. (B) The chemokine transcripts detected in alveolar macrophages. Arrows indicate FDR q < 0.05 for effect of pneumonia history. (C) The phagocytosis receptor transcripts detected in alveolar macrophages. Arrows indicate FDR q < 0.05 for effect of pneumonia history. (D) Transcripts differentiating recruited versus autochthonous alveolar macrophages in prior studies of replacement after clodronate depletion (19). Asterisks (*) indicate FDR q < 0.05 for effect of pneumonia history, with changes in the direction consistent with monocyte-derived alveolar macrophages in the experienced group, and hashtag (#) indicates FDR q < 0.05 for effect of pneumonia history, with changes in the opposite direction. (E) Surface protein levels of surface markers implicated in transcriptome studies as differing between naive and experienced mice at the mRNA level. MFI values on alveolar macrophages were plotted for each surface marker, with data collected over 2–3 independent experiments, and each data point representing an individual animal, and horizontal lines representing group means. Asterisks (*) indicate comparisons reaching statistical significance (P < 0.05) using unpaired 2-tailed Student’s t tests. (F) Protein levels of soluble cytokines implicated in transcriptome studies as differing between naive and experienced mice at the mRNA level. Concentrations were quantified by ELISA in left lung homogenates (LLH) from naive or experienced mice infected 4 or 7 hours with serotype 3 pneumococcus. Data were collected over 2–3 independent experiments, with each data point representing an individual animal and bars representing group means. Asterisks (*) indicate comparisons reaching statistical significance (P < 0.05) using 2-way ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts